Earth Science Tech, Inc. last reported quarterly results on Aug 7, 2026, for Q1 FY2027 (the quarter ended Jun 30, 2026): revenue of $9.0 million and diluted EPS of $0.00. It usually reports 38 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q2 FY2027, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 7, 2026
38 days after quarter end
|
Q1 FY2027
ended Jun 30, 2026
|
9
|
1
|
0.00
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ETST (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1538495
- Former names
- Ultimate Novelty Sports Inc. (until Apr 17, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.